"
Team:Penn/Too Soon To Treat
From 2013.igem.org
(Difference between revisions)
| Line 25: | Line 25: | ||
<div id="text"> | <div id="text"> | ||
<div class = "textwrap"> | <div class = "textwrap"> | ||
| - | <header><h1><b><center>The | + | <header><h1><b><center>The Potential of Epigenetic Therapy and the Need for Elucidation of Risks</center></b></h1></header> |
<p> </p> | <p> </p> | ||
| Line 34: | Line 34: | ||
<p> </p> | <p> </p> | ||
<p> </p> | <p> </p> | ||
| - | <embed src="https://static.igem.org/mediawiki/2013/a/ae/Penn_iGEM_2013_PBJ_Article.pdf" width='800' height=' | + | <embed src="https://static.igem.org/mediawiki/2013/a/ae/Penn_iGEM_2013_PBJ_Article.pdf" width='800' height='600'> |
</div> | </div> | ||
Latest revision as of 03:52, 29 October 2013
The Potential of Epigenetic Therapy and the Need for Elucidation of Risks
This article has been accepted for publication by "the nation's premiere peer-reviewed undergraduate bioethics journal", the Penn Bioethics Journal. We're very appreciative of their support and excited to spread the word about iGEM and epigenetic engineering amongst their broad readership.
Download the full article as a PDF.
